期刊
ACTA PAEDIATRICA
卷 110, 期 4, 页码 1315-1321出版社
WILEY
DOI: 10.1111/apa.15590
关键词
Crohn's disease; interleukin-23; Langerhans cell histiocytosis
类别
资金
- Cancerfonden
- Stockholm County Council
- Barncancerfonden
This study presented the first case series of patients with both Langerhans cell histiocytosis (LCH) and Crohn's disease (CD), highlighting diagnostic challenges and elevated IL-23 levels in LCH patients, with a correlation between lesional LCH cells and circulating IL-23 levels. Both CD and LCH should be considered in patients with inflammatory gastrointestinal involvement, with the IL-23 pathway being a common immunological trait between these two granulomatous diseases.
Aim To present the first case series of patients with Langerhans cell histiocytosis (LCH) also affected by Crohn's disease (CD), both of which are granulomatous diseases, and in LCH investigate the role of interleukin (IL)-23, which is a well-described disease mediator in CD. Methods A case series of three patients with LCH and CD were described; a cohort of LCH patients (n = 55) as well as controls (n = 55) were analysed for circulating IL-23 levels; and the relation between the percentage of LCH cells in lesions and circulating IL-23 levels was analysed in seven LCH patients. Results Differential diagnostic challenges for these two granulomatous diseases were highlighted in the case series, and it took up to 3 years to diagnose CD. Elevated IL-23 levels were found in LCH patients. The amount of lesional LCH cells correlated with the levels of circulating IL-23. Conclusion Both CD and LCH should be considered in patients with inflammatory gastrointestinal involvement. The IL-23 pathway is a common immunological trait between these two granulomatous diseases.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据